AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes.
Molecular Weight:
478.5
Purity:
97.07%
CAS Number:
[919783-22-5]
Formula:
C24H26N6O5
Target:
Glucokinase
T26712
* VAT and and shipping costs not included. Errors and price changes excepted